Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/3076
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorCANALE, Daniele-
dc.contributor.authorBRAGANCA, Ana Carolina de-
dc.contributor.authorGONCALVES, Janana-
dc.contributor.authorSHIMIZU, Maria Helosa M.-
dc.contributor.authorVOLPINI, Rildo A.-
dc.contributor.authorANDRADE, Lucia-
dc.contributor.authorSEGURO, Antonio Carlos-
dc.date.accessioned2013-10-11T21:30:45Z-
dc.date.available2013-10-11T21:30:45Z-
dc.date.issued2013-
dc.identifier.citationNEPHROLOGY DIALYSIS TRANSPLANTATION, v.28, suppl.1, p.115-116, 2013-
dc.identifier.issn0931-0509-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/3076-
dc.description.abstractIntroduction and Aims:Vitamin D deficiency (VDD) is highly prevalent among HIV-infected individuals. Tenofovir disoproxil fumarate (TDF), a widely used component of antiretroviral regimens for HIV treatment, has been associated with comorbidities, some of which have been attributed to renal toxicity and metabolic syndrome. The aim of the study was to investigate the effect of VDD on TDF treated rats. Methods:Wistar rats were randomly divided into four groups: control (C, n = 9), receiving a standard diet for 60 days; VDD (n = 6), receiving a free-vitamin D diet for 60 days; TDF (n = 9), receiving a standard diet for 60 days with the addition of TDF (50 mg/kg food) for the last 30 days; and VDD+TDF (n = 7) received a free-vitamin D diet for 60 days with the addition of TDF (50 mg/kg food) for the last 30 days. We measured inulin clearance (GFR, mL/min/100g); blood pressure (BP, mmHg), renal blood flow and calculated renal vascular resistance (RVR, mmHg/mL/min); serum levels of 25-hydroxyvitamin D (25(OH)D, ng/mL), cholesterol (mg/dL) and triglycerides (mg/dL); urinary sodium excretion (UVNa,mEq/24h). In renal tissue, we immunoblotted for angiotensin II (AII), endothelial nitric oxide synthase (eNOS) and vitamin D receptor (VDR). Data are expressed as mean ± SEM. Results:Vitamin D levels were similar in C (15.4±1 ng/mL) and TDF (14.8±1.3 ng/mL) groups and <1.5 ng/mL in VDD groups. Body weight, water intake and food ingestion were not different among the 4 groups. Treatment with TDF led to impaired renal function, hypertension, higher RVR and dyslipidemia. Administration of TDF also increased protein expression of AII and VDR. Association of TDF and VDD exacerbates TDF nephrotoxicity, as well as metabolic syndrome. Furthermore, VDD+TDF group showed urinary sodium retention. The increased VDR protein expression in TDF groups may represent a compensatory effect to decrease renal injury. Conclusions:VDD aggravates renovascular effects and TDF-induced renal failure at least in part due to the involvement of renin-angiotensin-aldosterone system. Therefore, the assessment of vitamin D is important in HIV patients receiving TDF.-
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.language.isoeng-
dc.publisherOXFORD UNIV PRESS-
dc.relation.ispartofNephrology Dialysis Transplantation-
dc.rightsrestrictedAccess-
dc.titleVITAMIN D DEFICIENCY AGGRAVATES TENOFOVIR INDUCED METABOLIC SYNDROME AND RENAL FAILURE-
dc.typeconferenceObject-
dc.rights.holderCopyright OXFORD UNIV PRESS-
dc.description.conferencedateMAY 18-21, 2013-
dc.description.conferencelocalIstanbul, TURKEY-
dc.description.conferencename50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress-
dc.subject.wosTransplantation-
dc.subject.wosUrology & Nephrology-
dc.type.categorymeeting abstract-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage115-
hcfmusp.description.endpage116-
hcfmusp.description.issuesuppl 1-
hcfmusp.description.volume28-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000319498200297-
hcfmusp.publisher.cityOXFORD-
hcfmusp.publisher.countryENGLAND-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipCNPq-
hcfmusp.remissive.sponsorshipFAPESP-
Appears in Collections:

Comunicações em Eventos - FM/MCM
Departamento de Clínica Médica - FM/MCM

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC

Comunicações em Eventos - LIM/12
LIM/12 - Laboratório de Pesquisa Básica em Doenças Renais


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.